Alcinous Pharmaceuticals, Inc. — Form D
Alcinous Pharmaceuticals, Inc. of RUMFORD, RI, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-16. The offering totals $600K, of which $100K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-04-16
- Form: D
- Accession: 0001809300-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $600K
- Amount sold: $100K
- Remaining: $500K
- Minimum investment: $1
- Investors: 2
- Date of first sale: 2020-04-03
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-365160
Issuer
- Name: Alcinous Pharmaceuticals, Inc.
- CIK: 0001809300
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 14 BICKNELL AVENUE, RUMFORD, RI, 02916
- Phone: 4015293190
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Benjamin J Barlock | Director | Rumford, RI |
| Nicholas A DaSilva | Director | Rumford, RI |
| Kenneth N Rose | Director | Rumford, RI |
| Nicholas A DaSilva | Executive Officer | Rumford, RI |
| Kenneth N Rose | Executive Officer | Rumford, RI |
More